LORA WHEELER: Open Payments
NPI 1952651655 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,658 in 97 payments from 20 companies in 2025. Trend: 2023 $1,863 · 2024 $2,915 · 2025 $1,658
Food & beverage: $1,658
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $274 |
| Bayer Healthcare Pharmaceuticals Inc. | 17 | $217 |
| Merck Sharp & Dohme LLC | 8 | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $149 |
| AstraZeneca Pharmaceuticals LP | 7 | $145 |
| United Therapeutics Corporation | 4 | $119 |
| Novo Nordisk Inc | 6 | $92 |
| Alnylam Pharmaceuticals Inc. | 3 | $81 |
| Kestra Medical Technology Services, Inc. | 4 | $77 |
| E.R. Squibb & Sons, L.L.C. | 4 | $76 |
Products named: LEQVIO, JARDIANCE, Kerendia, Tyvaso, WINREVAIR, Ozempic, FARXIGA, AMVUTTRA.
Industry payments across TN — which companies pay providers there.
